Summary
| Herb Id: TCMCG044 | Herb name: Papaver somniferum |
| Function: To fortify spleen and promote digestion, clear heat and disinhibit urine. | Indication: Stomach reflux, abdominal pain, diarrhea, prolapse of rectum. |
Ingredient
| Ingredient_name: 11-oxotriacontanoic acid | Alias: 11-oxotriacontanoicacid |
| Ingredient_formula: C30H58O3 | Ingredient_Smile: CCCCCCCCCCCCCCCCCCCC(=O)CCCCCCCCCC(=O)O |
| Ingredient_weight: 466.8 g/mol | OB_score: NA |
| PubChem_id: 5320340 | EC: - |
| Ingredient_name: α-narcotine | Alias: alpha-narcotine |
| Ingredient_formula: C22H23NO7 | Ingredient_Smile: CN1CCC2=CC3=C(C(=C2C1C4C5=C(C(=C(C=C5)OC)OC)C(=O)O4)OC)OCO3 |
| Ingredient_weight: 413.4 g/mol | OB_score: NA |
| PubChem_id: 275196 | EC: 1.1.1.415 [VIEW IN KEGG] 2.1.1.352 [VIEW IN KEGG] |
| Ingredient_name: beta-narcotine | Alias: AKOS003673314; IDI1_000323; CHEBI:95149; SCHEMBL14386820; β-narcotine; AC1L2EQH; MolPort-006-822-780; 6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3H-2-benzofuran-1-one; KBio1_000323; DivK1c_000323; CTK8G2016; NINDS_000323; LS-84359; 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (R-(R*,R*))- |
| Ingredient_formula: C22H23NO7 | Ingredient_Smile: CN1CCC2=CC3=C(C(=C2C1C4C5=C(C(=C(C=C5)OC)OC)C(=O)O4)OC)OCO3 |
| Ingredient_weight: 413.4 g/mol | OB_score: NA |
| PubChem_id: 19728 | EC: 1.1.1.415 [VIEW IN KEGG] 2.1.1.352 [VIEW IN KEGG] |
| Ingredient_name: caffeic acid | Alias: Caffeate; Lopac-C-0625; 71693-97-5; DivK1c_006624; KBio2_007302; (Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; NCGC00015206-02; CAS-3331-39-5; 60020_FLUKA; AI3-63211; 3-(3,4-Dihydroxyphenyl)-2-propenoic acid polymer; (E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; NSC623438; 4-(2'-Carboxyvinyl)-1,2-dihydroxybenzene; KBio2_004734; (2Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; CHEMBL1320034; AIDS-002287; AIDS002287; 501-16-6; CHEBI:36281; Prestwick1_000902; KBio1_001568; 3-(3,4-Dihydroxyphenyl)-2-propenoic acid; AKOS000273846; OR1165; SMR000058214; Spectrum2_001612; 3,4-dihydroxycinnamate; (Z)-3-(3,4-dihydroxyphenyl)acrylic acid; Caffeicacid; KOP; AC1NO658; CCRIS 847; Caffeic acid dehydrogenation homopolymer; SPECTRUM1503987; Spectrum4_001694; SCHEMBL3682144; NCGC00017364-01; NCGC00022654-08; 4-(2-Carboxyethenyl)-1,2-dihydroxybenzene; 78734C5A-1281-44D4-B8A0-A3188AD437E3; cis-Caffeic acid; 3-(3,4-dihydroxyphenyl)acrylic acid; Cinnamic acid, 3,4-dihydroxy-; KBioGR_001988; 3,4-Dihydroxybenzeneacrylic acid; 3,4-dihydroxycinnamic acid; trans-caffeic acid; AIDS-026339; NCGC00015206-01; HSDB 7088; ZINC4482687; (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; 3-(3,4-dihydroxyphenyl)prop-2-enoate; Isocaffeic acid; SBB006475; InChI=1/C9H8O4/c10-7-3-1-6(5-8(7)11)2-4-9(12)13/h1-5,10-11H,(H,12,13)/b4-2; NCGC00017364-02; EU-0100208; C01197; MolPort-001-759-162; KBioSS_002166; Caffeic acid pure; caffeic acid ; trans-Caffeate; (2E)-3-(3,4-dihydroxyphenyl)acrylic acid; NSC 57197; (2E)-3-(3,4-Dihydroxyphenyl)-2-propenoic acid; Spectrum_001686; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, (E)-; KBio2_002166; Caffeic acid, cis-; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-; 3,4-Dihydroxybenzeneacrylate; 3-(3,4-Dihydroxy phenyl)-2-propenoic acid; 4361-87-9; 3,4-Dihydroxy-trans-cinnamate; caffeicacid; AR-360/40806927; EINECS 206-361-2; 60018_FLUKA; Caffeic acid polymer; (E)-3-(3,4-dihydroxyphenyl)acrylic acid; NCGC00022654-04; ZX-AL002121; C0625_SIGMA; SDCCGMLS-0002982.P003; 3-(3,4-Dihydroxyphenyl)-2-propenoic acid, homopolymer; SPBio_001643; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)- (9CI); NCGC00017364-03; 3-(3,4-dihydroxyphenyl)prop-2-enoic acid; AC1LU7RL; SPBio_002943; CHEBI:16433; AIDS026339; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, homopolymer; CHEBI:17395; TNP00311; SpecPlus_000528; Prestwick0_000902; MLS000069738; 3,4-dihydroxy-cinnamic acid; 3-(3,4-Dihydroxyphenyl)propenoic acid; NCI60_004400; NSC57197 |
| Ingredient_formula: C9H8O4 | Ingredient_Smile: C1=CC(=C(C=C1C=CC(=O)O)O)O |
| Ingredient_weight: 180.16 | OB_score: 25.76439804 |
| PubChem_id: 689043 | EC: 1.1.1.110 [VIEW IN KEGG] 1.1.1.237 [VIEW IN KEGG] 1.2.3.13 [VIEW IN KEGG] 1.3.1.12 [VIEW IN KEGG] 1.3.1.13 [VIEW IN KEGG] 1.4.1.20 [VIEW IN KEGG] 1.4.3.2 [VIEW IN KEGG] 1.13.11.27 [VIEW IN KEGG] 1.13.11.46 [VIEW IN KEGG] 2.5.1.111 [VIEW IN KEGG] 2.6.1.1 [VIEW IN KEGG] 2.6.1.5 [VIEW IN KEGG] 2.6.1.9 [VIEW IN KEGG] 2.6.1.57 [VIEW IN KEGG] 2.6.1.58 [VIEW IN KEGG] 2.6.1.103 [VIEW IN KEGG] 4.1.1.80 [VIEW IN KEGG] 5.3.2.1 [VIEW IN KEGG] 1.13.11.22 [VIEW IN KEGG] 1.14.18.1 [VIEW IN KEGG] 2.1.1.68 [VIEW IN KEGG] 2.8.3.23 [VIEW IN KEGG] 3.1.1.42 [VIEW IN KEGG] 4.1.1.102 [VIEW IN KEGG] 6.2.1.12 [VIEW IN KEGG] 3.1.1.55 [VIEW IN KEGG] 1.3.1.87 [VIEW IN KEGG] 1.13.11.16 [VIEW IN KEGG] 1.14.13.127 [VIEW IN KEGG] |
| Ingredient_name: caffeic acid dimethyl ether | Alias: UNII-1EUC2RA0WK; caffeicacid dimethyl ether; OR6575; (Z)-3,4-Dimethoxycinnamic acid; HJBWJAPEBGSQPR-XQRVVYSFSA-N; 1EUC2RA0WK; NSC 4323; 3,4-Dimethoxycinnamic acid, (Z)-; (Z)-3-(3,4-dimethoxyphenyl)prop-2-enoic acid; AC1LUMLO; Cinnamic acid, 3,4-dimethoxy-, cis-; 81EAFE3E-9D74-4DF4-8165-71BA55ADB569; Cinnamic acid, 3,4-dimethoxy- (8CI); 2-Propenoic acid, 3-(3,4-dimethoxyphenyl)-, (2Z)-; AI3-24427; Cinnamic acid, 3,4-dimethoxy-, (Z)-; o-Methylferulic acid; (2Z)-3-(3,4-Dimethoxyphenyl)-2-propenoic acid; NSC 43569; EINECS 219-025-5; 2-Propenoic acid, 3-(3,4-dimethoxyphenyl)-, (Z)-; 14737-88-3; ZINC6007189; (2Z)-3-(3,4-DIMETHOXYPHENYL)PROP-2-ENOIC ACID |
| Ingredient_formula: C11H12O4 | Ingredient_Smile: COC1=C(C=C(C=C1)C=CC(=O)O)OC |
| Ingredient_weight: 208.21 g/mol | OB_score: NA |
| PubChem_id: 1585026 | EC: 2.1.1.108 [VIEW IN KEGG] 1.1.1.195 [VIEW IN KEGG] 1.2.1.44 [VIEW IN KEGG] 1.2.1.68 [VIEW IN KEGG] 2.1.1.68 [VIEW IN KEGG] 2.8.3.15 [VIEW IN KEGG] 4.1.99.11 [VIEW IN KEGG] |
| Ingredient_name: codeine | Alias: Morphinan-6-alpha-ol, 7,8-didehydro-4,5-alpha-epoxy-3-methoxy-17-methyl-; HSDB 3043; O(3)-methylmorphine; Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-; 7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol; C06174; l-Codeine; CCRIS 7555; Morphine monomethyl ether; C1653_SIGMA; Methylmorphine; Codeine; CHEBI:16714; 3-methoxy-17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-6alpha-ol; (5alpha,6alpha)-17-methyl-3-(methyloxy)-7,8-didehydro-4,5-epoxymorphinan-6-ol; Morphinan-6alpha-ol, 7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methyl- (8CI); Coducept; Norcodeine, N-methyl; 76-57-3; Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5-alpha,6-alpha)- (9CI); Codicept; Morphine-3-methyl ester; Codeine anhydrous; O3-Methylmorphine; EINECS 200-969-1; Morphine 3-methyl ether; Norcodine, N-methyl; Codein; Morphine-3-methyl ether; STOCK1N-42851; (-)-Codeine; Codeine solution; BB_NC-0138; Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)- (9CI); 7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol; C5901_SIGMA; Morphinan-6alpha-ol, 7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methyl- |
| Ingredient_formula: C18H21NO3 | Ingredient_Smile: CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O |
| Ingredient_weight: 299.36 | OB_score: 45.47890504 |
| PubChem_id: 5284371 | EC: 1.14.14.102 [VIEW IN KEGG] 1.14.18.1 [VIEW IN KEGG] 1.14.19.66 [VIEW IN KEGG] 2.1.1.115 [VIEW IN KEGG] 2.1.1.140 [VIEW IN KEGG] 1.1.1.247 [VIEW IN KEGG] 1.14.11.32 [VIEW IN KEGG] 1.14.14.1 [VIEW IN KEGG] 2.4.1.17 [VIEW IN KEGG] |
| Ingredient_name: codonolactone | Alias: NA |
| Ingredient_formula: C15H20O3 | Ingredient_Smile: CC1=C2CC3C(=C)CCCC3(CC2(OC1=O)O)C |
| Ingredient_weight: 248.32 g/mol | OB_score: NA |
| PubChem_id: 155948 | EC: 1.3.1.47 [VIEW IN KEGG] 1.14.14.169 [VIEW IN KEGG] 1.1.1.288 [VIEW IN KEGG] 1.2.3.14 [VIEW IN KEGG] 1.1.1.340 [VIEW IN KEGG] 1.14.13.170 [VIEW IN KEGG] 1.14.13.171 [VIEW IN KEGG] |
| Ingredient_name: Cryptogenin | Alias: Cryptogenine; 3-beta,26-Dihydroxycholest-5-ene-12,22-dione; cryptogenin; Cholest-5-ene-16,22-dione, 3beta,26-dihydroxy-, (20S,25R)- (8CI); Cryptogenine [French]; 3-beta,26-Dihydroxycholest-5-ene-12,22-dione [French]; BXC9X8B37J; 3beta,26-Dihydroxycholest-5-ene-16,22-dione; UNII-BXC9X8B37J; NSC 93751; Cholest-5-ene-16,22-dione, 3-beta,26-dihydroxy-, (20S,25R)- (8CI); Cholest-5-ene-16,22-dione, 3,26-dihydroxy-, (3-beta,25R)-; (3-beta,25R)-3,26-Dihydroxycholest-5-ene-16,22-dione |
| Ingredient_formula: C27H42O4 | Ingredient_Smile: [H+].CC(CCC(=O)C(C)C1C(=O)CC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)CO |
| Ingredient_weight: 430.62 | OB_score: 35.11397536 |
| PubChem_id: 56840953 | EC: 2.4.1.192 [VIEW IN KEGG] 1.1.1.181 [VIEW IN KEGG] |
| Ingredient_name: cryptopine | Alias: 11,12-Dimethoxy-6,8,9,15-tetrahydro[1,3]benzodioxolo[4,5-c]benzo[g]azecin-14(7H)-one; NSC-645287; AC1L82KR; NSC645287; CHEMBL2000522; AC1Q6ON1; NCI60_015427 |
| Ingredient_formula: C21H23NO5 | Ingredient_Smile: CN1CCC2=CC(=C(C=C2C(=O)CC3=C(C1)C4=C(C=C3)OCO4)OC)OC |
| Ingredient_weight: 369.41 | OB_score: NA |
| PubChem_id: 72616 | EC: 1.14.14.97 [VIEW IN KEGG] 2.1.1.353 [VIEW IN KEGG] 2.3.1.289 [VIEW IN KEGG] |
| Ingredient_name: cycloartenol | Alias: CF58DF82-6B90-40E1-B241-3FA99C98DA64; Cycloartenol; 9,19-Cyclolanost-24-en-3-ol, (3beta)-; C01902; 9beta,19-Cyclo-24-lanosten-3beta-ol; SCHEMBL561141; Cycloarterenol; 469-38-5; NSC 670193 |
| Ingredient_formula: C30H50O | Ingredient_Smile: CC(CCC=C(C)C)C1CCC2(C1(CCC34C2CCC5C3(C4)CCC(C5(C)C)O)C)C |
| Ingredient_weight: 426.7 g/mol | OB_score: NA |
| PubChem_id: 92110 | EC: - |
| Ingredient_name: cycloartenone | Alias: Cycloartenone; CYCLOARTENONE; CHEMBL226084; 511-63-7 |
| Ingredient_formula: C30H48O | Ingredient_Smile: CC(CCC=C(C)C)C1CCC2(C1(CCC34C2CCC5C3(C4)CCC(=O)C5(C)C)C)C |
| Ingredient_weight: 424.7 | OB_score: 40.57046636 |
| PubChem_id: 12305362 | EC: - |
| Ingredient_name: dl-laudanidine | Alias: NA |
| Ingredient_formula: C20H25NO4 | Ingredient_Smile: CN1CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)O)OC)OC |
| Ingredient_weight: NA | OB_score: NA |
| PubChem_id: NA | EC: 2.1.1.291 [VIEW IN KEGG] 1.3.3.8 [VIEW IN KEGG] |
| Ingredient_name: floripavine | Alias: NA |
| Ingredient_formula: C19H21NO4 | Ingredient_Smile: CN1CCC23C=C(C(=O)C=C2C1CC4=C3C(=C(C=C4)OC)O)OC |
| Ingredient_weight: NA | OB_score: NA |
| PubChem_id: NA | EC: 1.14.19.65 [VIEW IN KEGG] 1.14.19.73 [VIEW IN KEGG] 1.21.3.3 [VIEW IN KEGG] 2.1.1.117 [VIEW IN KEGG] 1.1.1.248 [VIEW IN KEGG] 1.14.19.67 [VIEW IN KEGG] 1.14.19.51 [VIEW IN KEGG] 2.1.1.337 [VIEW IN KEGG] |
| Ingredient_name: fluorocarpamine | Alias: NA |
| Ingredient_formula: C20H23N2O3+ | Ingredient_Smile: CC=C1C[NH+]2CCC34C2CC1C(N3C5=CC=CC=C5C4=O)C(=O)OC |
| Ingredient_weight: 339.4 g/mol | OB_score: NA |
| PubChem_id: 101688177 | EC: - |
| Ingredient_name: glaucine | Alias: AC1LL50T; (R)-5,6,6a,7-Tetrahydro-1,2,9,10-tetramethoxy-6-methyl-4H-dibenzo(de,g)quinoline; 38325-02-9; ZINC792622; EINECS 253-881-0; 4H-Dibenzo(de,g)quinoline, 5,6,6a,7-tetrahydro-1,2,9,10-tetramethoxy-6-methyl-, (R)-; FT-0698454; (?)-Glaucine; RUZIUYOSRDWYQF-OAHLLOKOSA-N; l-Glaucine; DTXSID70191691; (R)-5,6,6a,7-tetrahydro-1,2,9,10-tetramethoxy-6-methyl-4H-dibenzo[de,g]quinoline |
| Ingredient_formula: C21H25NO4 | Ingredient_Smile: CN1CCC2=CC(=C(C3=C2C1CC4=CC(=C(C=C43)OC)OC)OC)OC |
| Ingredient_weight: 355.43 | OB_score: NA |
| PubChem_id: 16754 | EC: 1.3.3.8 [VIEW IN KEGG] 2.1.1.89 [VIEW IN KEGG] 2.1.1.300 [VIEW IN KEGG] |
| Ingredient_name: glaudine | Alias: NA |
| Ingredient_formula: C22H25NO6 | Ingredient_Smile: CN1CCC2=CC(=C(C=C2C3C1C4=C(C(O3)OC)C5=C(C=C4)OCO5)OC)OC |
| Ingredient_weight: 399.4 g/mol | OB_score: NA |
| PubChem_id: 633491 | EC: 1.14.15.37 [VIEW IN KEGG] |
| Ingredient_name: hemipicacid | Alias: NA |
| Ingredient_formula: C10H10O6 | Ingredient_Smile: COC1=C(C(=C(C=C1)C(=O)O)C(=O)O)OC |
| Ingredient_weight: 226.18 g/mol | OB_score: NA |
| PubChem_id: 68209 | EC: 2.6.1.85 [VIEW IN KEGG] 2.6.1.86 [VIEW IN KEGG] 2.6.1.123 [VIEW IN KEGG] 3.3.2.13 [VIEW IN KEGG] 4.1.3.27 [VIEW IN KEGG] 4.1.3.40 [VIEW IN KEGG] 4.1.3.45 [VIEW IN KEGG] 4.2.1.151 [VIEW IN KEGG] 4.2.3.5 [VIEW IN KEGG] 5.4.4.2 [VIEW IN KEGG] 5.4.99.5 [VIEW IN KEGG] 1.3.1.12 [VIEW IN KEGG] 1.3.1.13 [VIEW IN KEGG] 2.6.1.57 [VIEW IN KEGG] 2.6.1.78 [VIEW IN KEGG] 2.6.1.79 [VIEW IN KEGG] 4.1.1.100 [VIEW IN KEGG] 4.2.1.51 [VIEW IN KEGG] 4.2.1.91 [VIEW IN KEGG] 2.2.1.9 [VIEW IN KEGG] 3.3.2.1 [VIEW IN KEGG] 4.2.99.21 [VIEW IN KEGG] |
| Ingredient_name: laudanosine | Alias: NA |
| Ingredient_formula: C21H27NO4 | Ingredient_Smile: CN1CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC |
| Ingredient_weight: 357.44 | OB_score: NA |
| PubChem_id: 73397 | EC: - |
| Ingredient_name: launobine | Alias: NA |
| Ingredient_formula: C18H17NO4 | Ingredient_Smile: COC1=C(C2=C(CC3C4=C2C5=C(C=C4CCN3)OCO5)C=C1)O |
| Ingredient_weight: 311.3 g/mol | OB_score: NA |
| PubChem_id: 5318956 | EC: - |
| Ingredient_name: m-hemipicacid | Alias: NA |
| Ingredient_formula: C10H10O6 | Ingredient_Smile: COC1=C(C=C(C(=C1)C(=O)O)C(=O)O)OC |
| Ingredient_weight: 226.18 g/mol | OB_score: NA |
| PubChem_id: 290988 | EC: 2.6.1.85 [VIEW IN KEGG] 2.6.1.86 [VIEW IN KEGG] 2.6.1.123 [VIEW IN KEGG] 3.3.2.13 [VIEW IN KEGG] 4.1.3.27 [VIEW IN KEGG] 4.1.3.40 [VIEW IN KEGG] 4.1.3.45 [VIEW IN KEGG] 4.2.1.151 [VIEW IN KEGG] 4.2.3.5 [VIEW IN KEGG] 5.4.4.2 [VIEW IN KEGG] 5.4.99.5 [VIEW IN KEGG] 1.3.1.12 [VIEW IN KEGG] 1.3.1.13 [VIEW IN KEGG] 2.6.1.57 [VIEW IN KEGG] 2.6.1.78 [VIEW IN KEGG] 2.6.1.79 [VIEW IN KEGG] 4.1.1.100 [VIEW IN KEGG] 4.2.1.51 [VIEW IN KEGG] 4.2.1.91 [VIEW IN KEGG] 2.2.1.9 [VIEW IN KEGG] 3.3.2.1 [VIEW IN KEGG] 4.2.99.21 [VIEW IN KEGG] |
| Ingredient_name: morphine | Alias: (5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol; 7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol; RMS; Hard stuff; Morpho; Cube juice; 47106-99-0; EINECS 200-320-2; 64-31-3 (SULFATE); (5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol; (-)(5.alpha.,6.alpha.)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol; Morphin; Nepenthe; Roxanol; (7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL; CCRIS 5762; AIDS-001987; Moscontin; Statex SR; Unkie; Morphia; Morphina [Italian]; M-Eslon; Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl-, (5alpha,6alpha)-; Morphinum; Ms Emma; 4,5alpha-Epoxy-17-methyl-7-morphinen-3,6alpha-diol; (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol; Dolcontin; 9H-9,9c-Iminoethanophenanthro(4,5-bcd)furan-3,5-diol, 4a,5,7a,8-tetrahydro-12-methyl-; Morphinism; Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5..alpha.,6.alpha.)-; MORPHINE, (5A,6A)-7,8-DIDEHYDRO-4,5-EPOXY-17-METHYLMORPHINIAN-3,6-DIOL, MORPHIUM, MORPHIA, DOLCONTIN, DUROMORPH, MORPHINA, NEPENTHE; 57-27-2 (FREE BASE ); (-)-Morphine; Dulcontin; 8053-16-5; Meconium; (-)Morphine sulfate; Ospalivina; NSC11441(SULFATE); Morphium; Morphin [German]; l-Morphine; 9H-9,9c-Iminoethanophenanthro(4,5-bcd)furan-3,5-diol, 4alpha,5,7alpha,8-tetrahydro-12-methyl-; Dreamer; HSDB 2134; Hocus; 85201-37-2; AIDS001987; 17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6alpha-diol; DEA No. 9300; Duromorph; Morfina [Italian]; Morphina; Morphinan-3,6-alpha-diol, 7,8-didehydro-4,5-alpha-epoxy-17-methyl-; MOI; CHEBI:17303 |
| Ingredient_formula: C17H19NO3 | Ingredient_Smile: CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O |
| Ingredient_weight: 285.34 | OB_score: 24.69391791 |
| PubChem_id: 5288826 | EC: 1.1.1.218 [VIEW IN KEGG] 1.1.1.247 [VIEW IN KEGG] 1.14.11.32 [VIEW IN KEGG] 1.14.14.1 [VIEW IN KEGG] 2.4.1.17 [VIEW IN KEGG] 2.3.1.145 [VIEW IN KEGG] 1.14.19.66 [VIEW IN KEGG] 2.1.1.115 [VIEW IN KEGG] 2.1.1.128 [VIEW IN KEGG] 2.1.1.140 [VIEW IN KEGG] |
| Ingredient_name: morroniside | Alias: Morroniside; HMS2205G07; SMR001397097; MLS002472991; CHEMBL2136065 |
| Ingredient_formula: C17H26O11 | Ingredient_Smile: CC1C2C(CC(O1)O)C(=COC2OC3C(C(C(C(O3)CO)O)O)O)C(=O)OC |
| Ingredient_weight: 406.4 g/mol | OB_score: NA |
| PubChem_id: 138107798 | EC: - |
| Ingredient_name: narceine | Alias: C09591; SCHEMBL24919; AC1L1R97; NARCEINE; 6-((6-(2-(Dimethylamino)ethyl)-2-methoxy-3,4-(methylenedioxy)phenyl)acetyl)-o-veratric acid; 131-28-2; ZINC1531508; 6-(2-(6-(2-(Dimethylamino)ethyl)-4-methoxybenzo[d][1,3]dioxol-5-yl)acetyl)-2,3-dimethoxybenzoic acid; 6-[[6-[2-(Dimethylamino)ethyl]-4-methoxy-1,3-benzodioxol-5-yl]acetyl]-2,3-dimethoxybenzoic acid; BG01735928; UNII-CTT09X2F1M; 6-[2-[6-(2-dimethylaminoethyl)-4-methoxy-1,3-benzodioxol-5-yl]acetyl]-2,3-dimethoxy-benzoic acid; Narcein; CHEMBL486305; AK-57589; 6-[[6-[2-(Dimethylamino)ethyl]-4-methoxy-1,3-benzodioxol-5-yl]acetyl]-2,3-dimethoxybenzoic acid, 9CI; C23H27NO8; CTT09X2F1M; 6-((6-[2-(Dimethylamino)ethyl]-4-methoxy-1,3-benzodioxol-5-yl)acetyl)-2,3-dimethoxybenzoic acid #; C-25403; AJ-26726; 6668AF; 5-19-09-00051 (Beilstein Handbook Reference); DEXMFYZAHXMZNM-UHFFFAOYSA-N; FT-0631763; BRN 0371009; NIH 10760; DTXSID40156833; Benzoic acid, 6-[[6-[2-(dimethylamino)ethyl]-4-methoxy-1,3-benzodioxol-5-yl]acetyl]-2,3-dimethoxy-; EINECS 205-021-0; o-Veratric acid, 6-((6-(2-(dimethylamino)ethyl)-2-methoxy-3,4-(methylenedioxy)phenyl)acetyl)-; AKOS022180680; 6-[2-[6-(2-dimethylaminoethyl)-4-methoxy-benzo[1,3]dioxol-5-yl]acetyl]-2,3-dimethoxy-benzoic acid; BENZOIC ACID,6-[2-[6-[2-(DIMETHYLAMINO)ETHYL]-4-METHOXY-1,3-BENZODIOXOL-5-YL]ACETYL]-2,3-DIMETHOXY-; LS-162042; 6-(2-{6-[2-(dimethylamino)ethyl]-4-methoxy-2H-1,3-benzodioxol-5-yl}acetyl)-2,3-dimethoxybenzoic acid; CHEBI:7480; ACM131282; 2,3-Dimethoxy-6-((6-(2-dimethylaminoethyl)-2-methoxy-3,4-methylendioxyphenyl)acetyl)benzosaeure; CTK1D7822; 6-[2-[6-(2-dimethylaminoethyl)-4-methoxy-1,3-benzodioxol-5-yl]acetyl]-2,3-dimethoxybenzoic acid; CC-32460; o-Veratric acid, 6-[[6-[2-(dimethylamino)ethyl]-2-methoxy-3,4-(methylenedioxy)phenyl]acetyl]- |
| Ingredient_formula: C23H27NO8 | Ingredient_Smile: CN(C)CCC1=CC2=C(C(=C1CC(=O)C3=C(C(=C(C=C3)OC)OC)C(=O)O)OC)OCO2 |
| Ingredient_weight: 445.46 | OB_score: NA |
| PubChem_id: 8564 | EC: - |
| Ingredient_name: Narcotoline | Alias: 3-(4-hydroxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-6,7-dimethoxy-3H-2-benzofuran-1-one; 6-Methyl-4-hydroxy-5,6,7,8-tetrahydro-5-(3-oxo-4,5-dimethoxy-1,3-dihydroisobenzofuran-1-yl)-1,3-dioxolo[4,5-g]isoquinoline; AC1MRPAC; narcotoline |
| Ingredient_formula: C21H21NO7 | Ingredient_Smile: CN1CCC2=CC3=C(C(=C2C1C4C5=C(C(=C(C=C5)OC)OC)C(=O)O4)O)OCO3 |
| Ingredient_weight: 399.39 | OB_score: 14.93378863 |
| PubChem_id: 442330 | EC: 1.1.1.415 [VIEW IN KEGG] 2.1.1.352 [VIEW IN KEGG] |
| Ingredient_name: Nardol | Alias: nardol; 1-methyl-4-methylidene-7-propan-2-yl-2,3,3a,5,6,7,8,8a-octahydroazulen-1-ol; AC1NSYYL; 10(14)-Guaien-4-ol |
| Ingredient_formula: C15H26O | Ingredient_Smile: CC(C)C1CCC(=C)C2CCC(C2C1)(C)O |
| Ingredient_weight: 222.37 g/mol | OB_score: 18.93476851 |
| PubChem_id: 5320013 | EC: 1.1.1.216 [VIEW IN KEGG] 1.1.1.354 [VIEW IN KEGG] 2.7.1.216 [VIEW IN KEGG] 3.1.7.6 [VIEW IN KEGG] 5.2.1.9 [VIEW IN KEGG] 4.2.3.85 [VIEW IN KEGG] 4.2.3.68 [VIEW IN KEGG] 1.14.14.59 [VIEW IN KEGG] 4.2.3.48 [VIEW IN KEGG] |
| Ingredient_name: neopine | Alias: CCG-39441; Neopin; C09594; KBio3_001981; EINECS 207-387-7; Spectrum2_001745; Spectrum4_001139; Spectrum5_001754; Neopine; DTXSID80196910; BSPBio_002761; SPBio_001850; SCHEMBL679477; UNII-TM43JB0IA8; 467-14-1; KBioGR_001657; (5alpha,6alpha)-8,14-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol; 27115-17-9; CHEBI:7509; Spectrum3_001011; TM43JB0IA8; BRD-K34252131-001-02-0; beta-Codeine |
| Ingredient_formula: C18H21NO3 | Ingredient_Smile: CN1CCC23C4C(CC=C2C1CC5=C3C(=C(C=C5)OC)O4)O |
| Ingredient_weight: 299.4 g/mol | OB_score: NA |
| PubChem_id: 118701633 | EC: 1.14.14.102 [VIEW IN KEGG] 1.14.18.1 [VIEW IN KEGG] 1.14.19.66 [VIEW IN KEGG] 2.1.1.115 [VIEW IN KEGG] 2.1.1.140 [VIEW IN KEGG] 1.1.1.247 [VIEW IN KEGG] 1.14.11.32 [VIEW IN KEGG] 1.14.14.1 [VIEW IN KEGG] 2.4.1.17 [VIEW IN KEGG] |
| Ingredient_name: neoprotoveratrine | Alias: NA |
| Ingredient_formula: C41H63NO15 | Ingredient_Smile: CCC(C)C(=O)OC1C(C2C(CN3CC(CCC3C2(C)O)C)C4C1(C5C(C(C6C7(C5(C4)OC6(C(CC7)OC(=O)C(C)(C(C)O)O)O)C)OC(=O)C)OC(=O)C)O)O |
| Ingredient_weight: 809.9 g/mol | OB_score: NA |
| PubChem_id: 18477544 | EC: - |
| Ingredient_name: oxotuberostemonine(i) | Alias: NA |
| Ingredient_formula: C22H31NO5 | Ingredient_Smile: CCC1C(C2C(C(=O)OC23CC(N4C3=C1CCCC4)C5CC(C(=O)O5)C)C)O |
| Ingredient_weight: NA | OB_score: NA |
| PubChem_id: NA | EC: - |
| Ingredient_name: papaverine | Alias: Cepaverin; AOB5339; 58-74-2; MFCD00012745; ZINC00056555; NCI60_003183; Drapavel; DSSTox_RID_77939; NCI-C56359; Myobid; BB_NC-0726; H754; Isoquinoline, 6,7-dimethoxy-1-veratryl-, hydrochloride; Papaverine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material; Dynovas; Artegodan; Papavarine chlorhydrate; DTXSID9025825; NCGC00094258-03; Isoquinoline,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-, hydrochloride; 1-[(3,4-Dimethoxyphenyl)methyl]6,7-dimethoxyisoquinoline; Alapav; Papacon; AIDS000185; NSC35443 (HCL); SMR000058283; KBioGR_000914; Spasmo-Nit; Papavarine hydrochloride; HMS1569F08; 1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-isoquinoline; DSSTox_CID_5825; Papaverine hydrochloride (JP17/USP); Pameion; NCGC00094258-06; BSPBio_002153; Chlorhydrate de papaverine [French]; Isoquinoline, 1-((3,4-dimethoxyphenyl)methyl)-6,7-dimethoxy-, hydrochloride (1:1); SBB080541; AIDS-000185; Oprea1_387689; 1-(3,4-Dimethoxy-benzyl)-6,7-dimethoxy-isoquinoline; I01-13837; Optenyl; CTK8G2272; Papaverine Hcl; WLN: T66 CNJ B1R CO1 DO1& HO1 IO1; Dispamil; Lopac0_000957; Isoquinoline, 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-; Isoquinoline,7-dimethoxy-1-veratryl-, hydrochloride; MLS000028497; KBio2_005607; Lapav; Ro-Papav; Papanerin-HCl [German]; Cardiospan; Tox21_110226_1; TNP00305; Pavnell; HMS1920F06; LP00957; Pavagrant; SR-01000003098-2; SDCCGMLS-0003037.P003; AC1L1LRO; 6,7,3',4'-Tetramethoxy-1-benzylisoquinoline hydrochloride; 6,7-Dimethoxy-1-veratrylisoquinoline; Isoquinoline, 6,7-dimethoxy-1-veratryl-(8Cl); TR-031684; Pavacot; Papaverine hydrochloride, United States Pharmacopeia (USP) Reference Standard; Paveron; Spectrum4_000467; Spectrum_000071; LS-267; SR-01000003098-11; Forpavin; Durapav; Cardoverina; Prestwick2_000583; Papaverine hydrochloride, powder; CCRIS 3804; 5-21-06-00182 (Beilstein Handbook Reference); Paverolan; 1-(3,4-Dimethoxybenzyl)-6,7-dimethoxyisoquinoline hydrochloride; 1-(3,4-dimethoxybenzyl)-6,7-dimethoxyisoquinoline; FT-0631269; ACon1_002094; NCGC00094258-04; EINECS 200-397-2; Papaverine; AC1Q3DLI; CHEMBL98123; Pavadel; 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline hydrochloride; 58-74-2 (Parent); InChI=1/C20H21NO4/c1-22-17-6-5-13(10-18(17)23-2)9-16-15-12-20(25-4)19(24-3)11-14(15)7-8-21-16/h5-8,10-12H,9H2,1-4H; REGID_for_CID_6084; BBC/116; Dipav; NCGC00094258-01; P0016; SPBio_002645; 6,7-Dimethoxy-1-(3,4-dimethoxybenzyl)isoquinoline; 6,7-Dimethoxy-1-veratrylisoquinoline hydrochloride; NCGC00261642-01; PubChem6305; Cerebid; 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline; Oprea1_810508; Vasal; Papanerin; P 3510; 23473EC6BQ; Pharmakon1600-01500459; C06533; Lopac-P-3510; Vaso-Pav; SCHEMBL121268; DivK1c_000321; Papaverina [Italian]; NSC136630; NSC 136630; KBio2_000471; Spectrum3_000537; MLS002222208; component of Copavin; 58-74-2 (FREE BASE ); Therapav; BG00717685; Prestwick1_000583; Pavacen; Copavin; AK-67336; Dilaves; PAP H; 4-[(6,7-dimethoxyisoquinolyl)methyl]-1,2-dimethoxybenzene, chloride; UNII-23473EC6BQ; NCGC00015810-01; Papaversan; Tox21_500957; DSSTox_GSID_25825; Papaverine chlorohydrate; Papaverine hydrochloride [USAN:JAN]; EINECS 200-502-1; EU-0100957; Robaxapap; NCGC00094258-02; Papaverine hydrochloride [USP:JAN]; Papaverine, hydrochloride; Papaverine (hydrochloride); PAPAVERINE HYDROCHLORIDE; Prestwick0_000583; MEGxp0_001880; Delapav; D02218; Pavacap; BPBio1_000470; Ceraspan; AS-13262; NCGC00015810-03; Isoquinoline, 1-((3,4-dimethoxyphenyl)methyl)-6,7-dimethoxy-, hydrochloride; Papanerin-hcl; NCGC00015810-12; KB-146860; RS 47; 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline;hydrochloride; CAS-61-25-6; UOTMYNBWXDUBNX-UHFFFAOYSA-N; Isoquinoline, 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-, hydrochloride (1:1); Papaverin; ACon1_000238; KBio2_003039; Prestwick3_000583; Pavabid (TN); Papaverine monohydrochloride; WLN: T66 CNJ B1R CO1 DO1& HO1 IO1 &GH; NSC757256; Pavatest; Papaverinium chloride; SR-01000003098; ST077145; ST023301; Pavakey; NSC-35443; BRN 0312930; Isoquinoline, 6,7-dimethoxy-1-veratryl- (8CI); SR-01000003098-9; 61-25-6 (HCL); SPBio_001015; NSC35443; MLS001148655; BSPBio_000426; IDI1_000321; Spectrum2_000978; Pavased; SPECTRUM1500459; Papanerine; NSC-757256; NCGC00094258-05; 6,7-Dimethoxy-1-(3,4-dimethoxybenzyl)-isoquinoline hydrochloride; KBioSS_000471; HY-18077A; Papaverine hydrochloride, European Pharmacopoeia (EP) Reference Standard; BG01663857; 1-(3,4-Dimethoxybenzyl)-6,7-dimethoxyisoquinolinehydrochloride; S-M-R; 1-((3,4-Dimethoxyphenyl)methyl)-6,7-dimethoxyisoquinoline; NINDS_000321; Papalease; Papaverine hydrochlorid; KBio3_001653; Pap-Kaps-150; MolPort-000-847-203; NCGC00015810-02; Isoquinoline, 6,7-dimethoxy-1-veratryl-; API0003748; CCG-40065; CS-5015; BAS 00674058; ARONIS23834; AKOS005111070; 61-25-6; NSC 35443; 4-[(6,7-Dimethoxyisoquinolyl)methyl]-1,2-dimethoxybenzene; C20H22ClNO4; 1-(3,7-dimethoxyisoquinoline hydrochloride; Isoquinoline, 6,7-dimethoxy-1-veratryl-, hydrochloride (8CI); Tox21_110226; 6,3',4'-Tetramethoxy-1-benzylisoquinoline hydrochloride; 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-isoquinoline; 1-{[3,4-bis(methyloxy)phenyl]methyl}-6,7-bis(methyloxy)isoquinoline; Spectrum5_001188; Opera_ID_1617; Prestwick_376; SR-01000003098-4; Isoquinoline, 1-((3,4-dimethoxyphenyl)methyl)-6,7-dimethoxy-; KBio1_000321 |
| Ingredient_formula: C20H21NO4 | Ingredient_Smile: COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC |
| Ingredient_weight: 339.39 | OB_score: 64.04275409 |
| PubChem_id: 4680 | EC: 1.3.3.8 [VIEW IN KEGG] 1.14.19.68 [VIEW IN KEGG] 2.1.1.122 [VIEW IN KEGG] 1.5.1.31 [VIEW IN KEGG] |
| Ingredient_name: Papaverrubine B | Alias: papaverrubine b |
| Ingredient_formula: C21H23NO6 | Ingredient_Smile: COC1C2=C(C=CC3=C2OCO3)C4C(O1)C5=CC(=C(C=C5CCN4)OC)OC |
| Ingredient_weight: 385.4 g/mol | OB_score: 10.302675 |
| PubChem_id: 12309624 | EC: - |
| Ingredient_name: parasorbic acid | Alias: Parascorbic acid; Kyselina paraskorbova; CHEBI:7926; AC1L9BCD; (+)-(6S)-PARASORBIC ACID; (2S)-2-methyl-2,3-dihydropyran-6-one; gamma-Hexenolactone; parasorbicacid; DCN48OUK3T; AKOS006278774; (S)-(+)-5,6-Dihydro-6-methyl-2H-pyran-2-one; Sorbic oil; C08502; Kyselina paraskorbova [Czech]; CHEMBL2252704; 2-Hexenoic acid, 5-hydroxy-, delta-lactone; Parasorbic acid; UNII-DCN48OUK3T; 2-Hexen-5,1-olide; 10048-32-5; (+)-Parasorbinsaeure [German]; (s)-2-hexen-5-olide; 2H-Pyran-2-one, 5,6-dihydro-6-methyl-, (6S)-; 5-17-09-00130 (Beilstein Handbook Reference); (+)-Parasorbinsaeure; BRN 0080685; SCHEMBL2686203; Hexenollactone |
| Ingredient_formula: C6H8O2 | Ingredient_Smile: CC1CC=CC(=O)O1 |
| Ingredient_weight: 112.13 g/mol | OB_score: NA |
| PubChem_id: 441575 | EC: 1.1.99.26 [VIEW IN KEGG] 3.7.1.10 [VIEW IN KEGG] 1.3.1.19 [VIEW IN KEGG] 1.14.12.3 [VIEW IN KEGG] 1.3.1.20 [VIEW IN KEGG] 1.1.1.174 [VIEW IN KEGG] 3.7.1.11 [VIEW IN KEGG] |
| Ingredient_name: protopine | Alias: DTXSID00178935; Bis(1,3)benzodioxolo(5,6-c:5',6'-g)azecin-14(6H)-one, 5,7,8,15-tetrahydro-6-methyl-; Bis[1,3]benzodioxolo[5,6-c:5',6'-g]azecin-14(6H)-one,5,7,8,15-tetrahydro-6-methyl-; AC1L4H3I; CHEMBL486179; 14-METHYL-7,9,20,22-TETRAOXA-14-AZAPENTACYCLO[15.7.0.0?,(1)(2).0?,(1)?.0(1)?,(2)(3)]TETRACOSA-1(24),4,6(10),11,17,19(23)-HEXAEN-2-ONE; CTK4F3162; MCULE-2865552640; BDBM50377937; 24240-05-9; AC1Q6P91; NCGC00385257-01_C20H19NO5_1,3-Benzodioxolo[5,6-c][1,3]benzodioxolo[5,6-g]azecin-14(6H)-one, 5,7,8,15-tetrahydro-6-methyl-; C20H19NO5; protopine ; Pseudoprotopine; MolPort-028-610-216; 6-methyl-5,7,8,15-tetrahydrobis[1,3]benzodioxolo[5,6-c:5',6'-g]azecin-14(6h)-one; 7,13a-Secoberbin-13a-one, 7-methyl-2,3:10,11-bis(methylenedioxy)-; ZINC31502517 |
| Ingredient_formula: C20H19NO5 | Ingredient_Smile: CN1CCC2=CC3=C(C=C2C(=O)CC4=C(C1)C5=C(C=C4)OCO5)OCO3 |
| Ingredient_weight: 353.37 | OB_score: NA |
| PubChem_id: 4970 | EC: 1.14.14.97 [VIEW IN KEGG] 1.14.14.98 [VIEW IN KEGG] |
| Ingredient_name: Protoporphyrin | Alias: 553-12-8 (FREE ACID); NSC2632 (FREE ACID); protoporphyrin; Ferrocytochrome; PROTOPORPHYRIN (PP); Ferrocytochrome b-561 |
| Ingredient_formula: C34H34N4O4 | Ingredient_Smile: CC1=C(C2=NC1=CC3=C(C(=C([N-]3)C=C4C(=C(C(=N4)C=C5C(=C(C(=C2)[N-]5)C)CCC(=O)O)CCC(=O)O)C)C)C=C)C.[Fe+2] |
| Ingredient_weight: 562.66 | OB_score: 30.86028979 |
| PubChem_id: 439347 | EC: 1.3.3.4 [VIEW IN KEGG] 1.3.5.3 [VIEW IN KEGG] 4.98.1.1 [VIEW IN KEGG] 6.6.1.1 [VIEW IN KEGG] |
| Ingredient_name: reticuline | Alias: CHEBI:17428; AC1L99KR; (R)-(-)-reticuline; (1R)-1,2,3,4-Tetrahydro-1-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2-methyl-7-isoquinolinol; AK552295; (1R)-1-(3-hydroxy-4-methoxybenzyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol; C05178; FT-0699770; MFCD28556897; ZINC901258; DTXSID80331501; L-Reticuline; CHEMBL401501; AKOS030242061; (1R)-1-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol; (R)-Reticuline; (-)-reticuline; SCHEMBL9587509; NCGC00247617-01; 3968-19-2; (R)-Reticuline (>80% ee); CTK1C2641 |
| Ingredient_formula: C19H23NO4 | Ingredient_Smile: CN1CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)O)O)OC |
| Ingredient_weight: 329.4 g/mol | OB_score: NA |
| PubChem_id: 439653 | EC: 1.14.19.51 [VIEW IN KEGG] 1.14.19.54 [VIEW IN KEGG] 1.21.3.3 [VIEW IN KEGG] 2.1.1.115 [VIEW IN KEGG] 2.1.1.116 [VIEW IN KEGG] 2.1.1.291 [VIEW IN KEGG] 2.1.1.337 [VIEW IN KEGG] 1.5.1.27 [VIEW IN KEGG] 1.14.19.67 [VIEW IN KEGG] 1.1.1.248 [VIEW IN KEGG] 2.3.1.150 [VIEW IN KEGG] |
| Ingredient_name: retrorsine | Alias: .beta.-Longilobine; BCJMNZRQJAVDLD-XRVQXMHSSA-N; RETRORSINE |
| Ingredient_formula: C18H25NO6 | Ingredient_Smile: CC=C1CC(C(C(=O)OCC2=CCN3C2C(CC3)OC1=O)(CO)O)C |
| Ingredient_weight: 351.4 g/mol | OB_score: NA |
| PubChem_id: 126968828 | EC: 1.14.13.101 [VIEW IN KEGG] |
| Ingredient_name: sanguinarine | Alias: Sanguinarine, 8CI); NSC-59270; sanguinarine ; NSC-35607; [1,6-c]-1,3-dioxolo[4,5-i]phenanthridinium, 13-methyl-, nitrate |
| Ingredient_formula: C20H14NO4+ | Ingredient_Smile: C[N+]1=C2C(=C3C=CC4=C(C3=C1)OCO4)C=CC5=CC6=C(C=C52)OCO6 |
| Ingredient_weight: 332.3 g/mol | OB_score: 37.80767752 |
| PubChem_id: 5154 | EC: 1.3.1.107 [VIEW IN KEGG] 1.3.3.8 [VIEW IN KEGG] 1.5.3.12 [VIEW IN KEGG] |
| Ingredient_name: Sanleng acid | Alias: AC1NT070; sanleng acid; (E)-6,9,10-trihydroxyoctadec-7-enoic acid |
| Ingredient_formula: C18H34O5 | Ingredient_Smile: CCCCCCCCC(C(C=CC(CCCCC(=O)O)O)O)O |
| Ingredient_weight: 330.46 | OB_score: 13.36564741 |
| PubChem_id: NA | EC: - |
| Ingredient_name: stigmasterol | Alias: (3beta,22E)-Stigmasta-5,22-dien-3-ol; (3S,8S,9S,10R,13R,14S,17R)-17-[(1R,4S)-4-ethyl-1,5-dimethyl-hex-2-enyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; stigmasta-5,22E-dien-3beta-ol; 24-Ethyl-5,22-cholestadien-3beta-ol; (24S)-Stigmast-5,22-dien-3beta-ol; Stigmasterin; Stigmasta-5,22-dien-3-ol, (3beta,22E)- (9CI); (24S)-5,22-Stigmastadien-3beta-ol; CCRIS 7476; NSC 8095; Delta5-Stigmasterol; (24S)-24-Ethylcholesta-5,22-dien-3beta-ol; AIDS-002709; Stigmasta-5,22-dien-3beta-ol (8CI); C05442; SBB012602; (3S,8S,9S,10R,13R,14S,17R)-17-[(E,1R,4S)-4-ethyl-1,5-dimethylhex-2-enyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5S)-5-ethyl-6-methyl-hept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; beta-Stigmasterol; stigmasta-5,22-dien-3-ol; ZINC04096712; Delta5,22-Stigmastadien-3beta-ol; (3S,8S,9S,10R,13R,14S,17R)-17-[(1R,4S)-4-ethyl-1,5-dimethylhex-2-enyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; stigmasterol ; SMP1_000280; Stigmasta-5,22-dien-3-ol, (3beta,22E)-; Stigmasta-5,22-dien-3-ol, (3beta)-; (3.beta.,22E)-Stigmasta-5,22-dien-3-ol; Stigmasta-5,22-dien-3-beta-ol; EINECS 201-482-7; 83-48-7; LMST01040123; (3S,8S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,8S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methyl-hept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; Stigmasta-5,22-dien-3beta-ol; (3S,8S,9S,10R,13R,14S,17R)-17-[(E,1R,4S)-4-ethyl-1,5-dimethyl-hex-2-enyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; QSPL 173; Stigmasterol; .delta.5,22-Stigmastadien-3.beta.-ol; AIDS002709; 24-Ethyl-5,22-cholestadien-3.beta.-ol; D5-Stigmasterol |
| Ingredient_formula: C29H48O | Ingredient_Smile: CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C |
| Ingredient_weight: 412.7 g/mol | OB_score: NA |
| PubChem_id: 5280794 | EC: 1.3.1.70 [VIEW IN KEGG] 1.3.1.72 [VIEW IN KEGG] 1.14.18.9 [VIEW IN KEGG] 1.14.19.41 [VIEW IN KEGG] 1.3.1.21 [VIEW IN KEGG] 1.14.18.11 [VIEW IN KEGG] 2.1.1.143 [VIEW IN KEGG] 5.3.3.5 [VIEW IN KEGG] 1.1.1.270 [VIEW IN KEGG] 1.14.19.20 [VIEW IN KEGG] |
| Ingredient_name: Stigmasterol-beta-D-glucoside | Alias: stigmasterol-beta-d-glucoside; stigmasterol-β-d-glucoside |
| Ingredient_formula: NA | Ingredient_Smile: CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C |
| Ingredient_weight: 484.7 | OB_score: 4.079801187 |
| PubChem_id: NA | EC: - |
| Ingredient_name: thebaine | Alias: NA |
| Ingredient_formula: C19H21NO3 | Ingredient_Smile: CN1CCC23C4C(=CC=C2C1CC5=C3C(=C(C=C5)OC)O4)OC |
| Ingredient_weight: 311.4 g/mol | OB_score: NA |
| PubChem_id: 5324289 | EC: 1.14.11.31 [VIEW IN KEGG] 1.14.11.32 [VIEW IN KEGG] 4.2.99.24 [VIEW IN KEGG] |
| Ingredient_name: Thellungianin F | Alias: [4-[(Z)-prop-1-enyl]phenyl] 2-methylbutanoate; AC1NT0ZM; thellungianin f |
| Ingredient_formula: NA | Ingredient_Smile: CCC(C)C(=O)OC1=CC=C(C=C1)C=CC |
| Ingredient_weight: 218.32 | OB_score: 27.55433918 |
| PubChem_id: NA | EC: - |